Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
NKTR
$73.02
-3.82%
NKTR · Nektar Therapeutics
$73.02
-2.90 (-3.82%)
At close · Aug 14
Market Cap
$2.49B
Shares
34.14M
All earnings calls
Earnings call · FY2024 Q4
Nektar Therapeutics Q4 FY2024 Earnings Call
Nektar Therapeutics Q4 FY2024 Earnings Call
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue · derived Q4
$29.18M
+22.1% YoY
Net income · derived Q4
$7.26M
Research materials
Open the source you need; every reader stays inside this workspace.
Listen and read together
Transcript
The spoken word highlights as audio plays. Select any word to seek to that moment.
29:58
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 12, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 14, 2025 · complete as-filed document